Our previous data have shown that let-7a microRNA suppresses its target transcript K-ras and inhibits glioma malignancy independent of PTEN.[13] In the current study, we investigated the role of let-7a and PKM2 in the glucose metabolism of glioma cells. Here, KRAS is linked to central nervous system cancer.